Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer
Status unconfirmed · Phase 1
Conditions studied: Head and Neck Cancer
In brief
RATIONALE: Radiofrequency ablation uses a high-frequency, electric current to kill tumor cells. Ultrasound-guided radiofrequency ablation may be effective treatment for thyroid cancer. PURPOSE: This phase I trial is studying the side effects of radiofrequency ablation in treating patients who are undergoing surgery for thyroid cancer.
Key facts
- Study ID
- NCT00103155
- Run by
- University of California, San Francisco
- Starts
- 2004-09-01
- Last updated by the study team
- 2013-09-20
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UCSF Comprehensive Cancer Center — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.